Keenova Announces Publication of XIAFLEX® (collagenase clostridium histolyticum) Manuscript in Translational Andrology and Urology

Summary

Keenova Therapeutics announced publication of a manuscript examining whether baseline penile pain influences treatment outcomes in men with Peyronie's disease treated with XIAFLEX. The publication represents a routine scientific dissemination event for an already-marketed drug.